Navigation Links
Helix BioPharma Announces Q1 2009 Financial Results
Date:12/11/2008

et loss from operations totaled $2,321,000 in the first quarter of fiscal 2009 (2008 - $1,644,000) for an increase of $677,000. Cash used in operating activities in the first quarter of fiscal 2009 totaled $1,618,000 (2008 - $1,643,000) resulting in a decrease of $25,000, despite the higher net loss from operations, and is attributable to changes in non-cash working capital, specifically higher accounts payable and accruals.

Financing activities

Financing activities in the first quarter of fiscal 2009 totaled $9,659,000 (2008 - $nil) and represents the private placement which was completed on October 2, 2008, where the Company issued 6,800,000 units at $1.68 per unit, for gross proceeds of $11,424,000.

Investing activities

Use of cash in investing activities for the in the first quarter of fiscal 2009 totaled $37,000 (2008 - $50,000) and represents capital acquisitions in both comparative quarters.

Liquidity, Capital Resources and outlook

Since inception, the Company has financed its operations from public and private sales of equity, the exercise of warrants and stock options, and, to a lesser extent, interest income from funds available for investment, government grants, investment tax credits, and revenues from distribution, licensing and contract services. Since the Company does not have net earnings from its operations, the Company's long-term liquidity depends on its ability to access the capital markets, which depends substantially on the success of the Company's ongoing research and development programs.

At October 31, 2008, the Company had cash and cash equivalents totaling $26,911,000 (July 31, 2008 - $19,057,000). The increase in cash and cash equivalents in the first quarter of fiscal 2009 is the result of a private placement completed on October 2, 2008 where the Company issued 6,800,000 units at $1.68 per unit,
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
2. Helix BioPharma Chairman resigns
3. Helix BioPharma Corp. announces fiscal 2007 results
4. Helix BioPharma Corp. announces management changes
5. Helix BioPharma announces $16.9 million private placement of common shares
6. Helix BioPharma announces Q1 2008 financial results
7. Helix BioPharma closes $16.9 million private placement of common shares
8. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
9. Helix BioPharma shareholders vote in favour of management
10. Helix BioPharma reports Q2 2008 highlights, financial results
11. W. Thomas Hodgson appointed to board of Helix BioPharma Corp.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014 A long-term ... partial breast irradiation (APBI) via interstitial brachytherapy suggests ... positive lymph nodes could be suitable to receive ... (ASTRO) guidelines place these patients in the "unsuitable" ... the 2014 ASTRO meeting, Beaumont Health System,s ...
(Date:9/17/2014)... PRINCETON, N.J. , Sept. 17, 2014 /PRNewswire/ ... developing targeted therapeutic devices to address infectious disease, cancer ... Sciences, Inc. (ESI), disclosed today that each company will ... Summit. On September 18 th , ... presentation entitled: "Exosomes: A Multiplexed Platform for Clinical Management." ...
(Date:9/17/2014)... 2014 JH Technologies announces ... in Irvine. JH Technologies, a leader in sales ... announced an expanded partnership with Leica Microsystems into the ... image analysis solutions will be featured at the grand ... new showroom facility is located within the JH Technologies ...
(Date:9/17/2014)... Intarcia Therapeutics, Inc. today announced the presentation ... cost and predictability of non-adherence in type 2 diabetes ... the European Association for the Study of Diabetes (EASD). ... Ph.D., of Analysis Group, Inc. presented data from the ... to characterize the prevalence of non-adherence and serial non-adherence, ...
Breaking Biology Technology:Partial Breast Irradiation With Interstitial Brachytherapy Appears Appropriate For Women Previously Considered Unsuitable 2Partial Breast Irradiation With Interstitial Brachytherapy Appears Appropriate For Women Previously Considered Unsuitable 3Partial Breast Irradiation With Interstitial Brachytherapy Appears Appropriate For Women Previously Considered Unsuitable 4Aethlon Medical and Exosome Sciences To Present at the Exosomes & SingleCell Analysis Summit 2Aethlon Medical and Exosome Sciences To Present at the Exosomes & SingleCell Analysis Summit 3JH Technologies displays newest microscope imaging technology at Southern California showroom grand opening 2JH Technologies displays newest microscope imaging technology at Southern California showroom grand opening 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 2Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 4Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 5
... ST. JOSEPH, Mich., July 16 GeneGo, Inc., ... biology and pathway,analysis, today announced that the University ... certified GeneGo Center of Excellence (COE). Miller,School of ... and advanced support. COE will provide a pathway ...
... Cell Therapeutics, Inc.,(CTI) (Nasdaq and MTA: CTIC) ... Patients and Providers Act of 2008, which,includes an ... such as Zevalin(R) (Ibritumomab Tiuxetan), overriding,President Bush,s veto., ... U.S. House of Representatives on,June 24, 2008 and ...
... the ... Treatment of Stuttering, ROANOKE, Va., ... non-profit research and,clinical center ( http://www.stuttering.org ) specializing ... stuttering,therapy with advanced behavioral, electronic and computer technologies that,significantly improve ...
Cached Biology Technology:University of Miami Miller School of Medicine Becomes a GeneGo Center of Excellence 218-Month Extension of Reimbursement Rates for Radioimmunotherapies Becomes Law After Congressional Override of Presidential Veto 218-Month Extension of Reimbursement Rates for Radioimmunotherapies Becomes Law After Congressional Override of Presidential Veto 3Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech 2Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech 3
(Date:9/16/2014)... the Columbia Center for Children,s Environmental Health at the ... demonstrate an association between childhood asthma and prenatal exposure ... household products. Results appear online in the journal ... mothers exposed during pregnancy to higher levels of the ... a 72 percent and 78 percent increase in risk ...
(Date:9/16/2014)... brakes" that time the generation of important cells in ... translate sound waves into electrical signals that are carried ... the arrangement of the cells is disordered, hearing is ... be published in The Journal of Neuroscience ... act as brakes to prevent hair cell generation until ...
(Date:9/16/2014)... species has its own bacterial identity. That,s the conclusion ... institutions who studied the genetic fingerprints of bacteria on ... , "This study demonstrates for the first time that ... ecological strategies possess very different microbial communities on their ... postdoctoral researcher in the UO,s Institute of Ecology and ...
Breaking Biology News(10 mins):Phthalates heighten risk for childhood asthma 2Phthalates heighten risk for childhood asthma 3Hey1 and Hey2 ensure inner ear 'hair cells' are made at the right time, in the right place 2Microbiome research shows each tree species has a unique bacterial identity 2
... an infectious question about eating at restaurants: How clean ... Pascall found that even when they washed dishes in ... to levels accepted in the Food and Drug Administration's ... and milk—can be safe havens for bacteria when dried ...
... with an overt reaction to toxins that cause oxidative ... health threats. , At the 233rd American Chemical Society ... Tech and the Edward Via Virginia College of Osteopathic ... biosensor prototype and correlations to brain tissue damage. ...
... level have on the activation of the female ... a researcher at the Cognitive Neuroscience Center (CNRS/Université ... from the National Institute of Mental Health (Bethesda, ... the first time, the neural networks involved in ...
Cached Biology News:Manual dishwashing study digs up dirt on dish cleanliness 2Manual dishwashing study digs up dirt on dish cleanliness 3Bacterial response to oxidation studied as toxin barometer 2Bacterial response to oxidation studied as toxin barometer 3The influence of the menstrual cycle on the female brain 2The influence of the menstrual cycle on the female brain 3The influence of the menstrual cycle on the female brain 4
... Software has been optimized for the analysis ... the software to quickly and accurately locate ... of an ELISA plate or each section ... has been customized to incorporate standard ELISA ...
For microscopy...
... description: Humidity wells in the base hold ... humidity and probe hydration around the edges ... the risk of waterbath contamination. This chamber ... waterbaths or hybridisation ovens. Linkage: This CLS ...
... R offers maximum application versatility for ... and cooling. Its active heating/cooling function ... temperature control ranges. Five different thermoblocks, ... test tubes, are available for: 0.5 ...
Biology Products: